Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: Relationship with DNA ploidy and classical prognostic factors

Pathology Research and Practice

Volumn 207, Issue 6, 2011, Pages 377-382

  Gonidi, Maria ^a   Athanassiadou, Anna Maria ^a   Patsouris, Efstratios ^a   Tsipis, Angelos ^a   Dimopoulos, Stavros ^a   Kyriakidou, Vassiliki ^a   Chelidonis, George ^a   Athanassiadou, Pauline ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Bcl 2; Breast carcinomas; DNA ploidy; UCP4

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 4;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CONTROLLED STUDY; GENE OVEREXPRESSION; GENOME IMPRINTING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; LYMPH NODE METASTASIS; PLOIDY; PROGNOSIS; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; FEMALE; GREECE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LOGISTIC MODELS; LYMPHATIC METASTASIS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79958756101     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.03.007     Document Type: Article

References (53)

1. Antonsson B. Mitochondria and the bcl-2 family proteins in apoptosis signaling pathways. Mol. Cell. Biochem. 2004, 256/257:141-155.
2. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001, 15:2922-2933.
3. Lassus P., Opitz-Araya X., Lazebnik Y. Requirement for caspase 2 in stress, induced apoptosis before mitochondrial permeabilization. Science 2002, 297:1352-1354.
4. Du C., Fang M., Li Y., Li L., Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102:33-42.
5. Bhatt K., Feng L., Pabla N., Liu K., Smith S., Dong Z. Effects of targeted bcl-2 expression in mitochondria or endoplasmic reticulum on renal tubular cell apoptosis. Hum. J. Physiol. Renal Physiol. 2008, 294:F499-F507.
6. Shimizu S., Eguchi Y., Kamiike W., Funahashi Y., Mignon A., Lacronique V., Matsura H., Tsujimoto Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl. Acad. Sci. 1998, 95:1455-1459.
7. Gallahy G., Pharoah P., Pinder S., Hsu F., Nielsen T., Ragaz J., Ellis I., Huntsman D., Caldas C. Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index. Clin. Cancer Res. 2006, 12:2468-2475.
8. Aggrarwal H., Lubana P., Jain D.K., Mathur R.K. Estimation of Bcl-2 protein in carcinoma of breast and its clinical correlation in locally advanced breast cancer. J. Cancer Res. Ther. 2007, 3:207-210.
9. Desagher S., Martinou J.C. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 2000, 10:369-377.
10. Ledesma A., de Lacoba M.G., Rial E. The mitochondrial uncoupling proteins. Gen. Biol. 2002, 3. 3015.1-3015.9.
11. Yu X., Mao W., Zhong A., Schow P., Brush J., Sherwood S., Adams S., Pan G. Characterization of novel UCP5/BMCP1 isoforms and differential regulation of UCP4 and UCP5 expression through dietary or temperature manipulation. FASEB J. 2000, 1611-1618.
12. Wei Z., Chigurupati S., Bagsiyao P., Henriquez A., Chan S.L. The brain uncoupling protein UCP4 attenuates mitochondrial toxin-induced cell death: role of extracellular signal-regulated kinases in bioenergetics adaptation and cell survival. Neurotox. Res. 2009, 16:14-29.
13. Bantis A., Gianopoulos A., Gonidi M., Liossi A., Aggelonidou E., Petrakakou E., Athanassiades P., Athanassiadou P. Expression of pl20 Ki-67 and PCNA as proliferation biomarkers in impact smears of prostate carcinoma and their prognostic value. Cytopathology 2004, 15:25-31.
14. Greene D.R., Taylor S.R., Wheeler T.M., Scardino P.T. DNA ploidy by image analysis of individuals foci of prostate cancer: a preliminary report. Cancer Res. 1991, 51:4084-4089.
15. Koss L.G., Melamed M.R. Recognizing and classifying cells. Koss' Diagnostic Cytology 2006, 119-120. Lippincot, Williams and Wilkins, Philadelphia. 5th ed. L.G. Koss, M.R. Melamed (Eds.).
16. Werner M., Chott A., Fabiano A., Battifora H. Effect of formalin fixation and processing on immunohistochemistry. Am. J. Surg. Pathol. 2000, 24:1016-1019.
17. Creager A.J., Geisinger K.R., Perrier N.D., Shen P., Shaw J.A., Young P.R., Case D., Levine E.A. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann. Surg. 2004, 239:61-66.
18. Cserni G. Effect of increasing the surface sampled by imprint cytology on the intraoperative assessment of axillary sentinel lymph nodes in breast cancer patients. Am. Surg. 2003, 69:419-423.
19. Ozzello L., DeRosa C., Habif D.V., Greene G.L. An immunohistochemical evaluation of progesterone receptor in frozen section, paraffin sections, and cytologic imprints of breast cascinomas. Cancer 1991, 67:455-462.
20. Aihara T., Munakata S., Morino H., Takatsuka Y. Touch imprint cytology and immunohistochemistry for assessment of sentinel lymph nodes in patients with breast cancer. Eur. J. Surg. Oncol. 2003, 29:845-848.
21. Aihara T., Munakata S., Morino H., Takatsuka Y. Comparison of frozen sections and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann. Surg. Oncol. 2004, 11:747-750.
22. Flens M.J., van der Valk P., Tadema T.M., Huysmans A.C., Risse E.K., van Tol G.A., Meijer C.J. The contribution of immunocytochemistry in diagnistic cytology. Comparisons and evaluation with immunohistology. Cancer 1990, 65:2704-2711.
23. Klevesath M.B., Godwin R.J., Bannon R., Munthali L., Coveney E. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions. Eur. J. Surg. Oncol. 2005, 31:490-494.
24. Sasaki M., Morimoti K., Koh M., Wakasa K., Haba T., Kinoshita H. Cytologic diagnosis of estrogen and progesterone receptors in breast imprints. Acta Cytol. 2002, 46:1056-1060.
25. WHO classification of Tumors of the Breast and Female Genital Organs, Lyon, France January 12-16 and March 16-20, 2002.
26. AJCC Cancer Staging Manual. 7th ed., Ann. Surg. Oncol. 17 (2010) 1471-1474.
27. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptosis program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996, 86:147-157.
28. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptotic protease. J. Exp. Med. 1996, 184:1-11.
29. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., Vaux D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding and antagonizing IAP proteins. Cell 2000, 102:43-53.
30. Li Y., Luo X., Wang X. Endonuclease G is an apoptotic DNAse when released from F mitochondria. Nature 2001, 412:27-29.
31. Mignotte, Vayssiere Mitochondria and apoptosis. Eur. J. Biochem. 1998, 252:1-15.
32. Le Bras M., Clément M.V., Pervaiz S., Brenner S. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol. Pathol. 2005, 20:205-219.
33. Baggetto L.G. Role of mitochondria in cancer. Eur. J. Cancer 1993, 29A:156-159.
34. Dang C.V., Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 1999, 24:68-72.
35. Liu S.L., Lin X., Shi D.Y., Cheng J., Wu C.Q., Zhang Y.D. Reactive oxygen species stimulate human hepatoma cell proliferation via cross-talk between P13/PKB and JNK signaling pathways. Arch. Biochem. Biophys. 2002, 406:173-182.
36. Pedersen P.L. Tumor mitochondria and bioenergetics of cancer cells. Prog. Exp. Tumor Res. 1978, 22:190-274.
37. Clemons M., Goss P. Estrogen and the risk of breast cancer. N. Engl. J. Med. 2001, 344:276-285.
38. Pedram A., Razandi M., Wallace D.C., Levin E.R. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol. Biol. Cell. 2006, 17:2125-2137.
39. Mobley J.A., Brueggemeier R.W. Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis 2004, 25:3-9.
40. Roy D., Cai Q., Felty Q., Narayan S. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-depended cancers. J. Toxicol. Environ. Health B Crit. Rev. 2007, 10:235-257.
41. Wallace D.C. Mouse models for mitochondrial disease. Am. J. Med. Genet. (Semin. Med. Genet.) 2001, 106:71-93.
42. Di Mauro S., Hirano M., Schon E. Mitochondrial Medicine 2006, Taylor and Francis.
43. Nogueira F.T., Borecky J., Vercesi A.E., Arruda P. Genomic structure and regulation of mitochondrial uncoupling protein genes in mammals and plants. Biosci. Rep. 2005, 25:209-226.
44. Smorodchenko A., Rupprecht A., Sarilova I., Ninnemann O., Bräuer A.U., Franke K., Schumacher S., Techritz S., Nitsch R., Schuelke M., Pohl E.E. Comparative analysis of uncoupling protein 4 distribution in various tissues under physiological conditions and during development. Biochim. Biophys. Acta 2009, 1788:2309-2319.
45. Kamga C.K., Zhang S., Fentress E., Wang Y. UCP4 is a key regulator of mitochondrial antioxidant defense PC12 cells. FASEB J. 2008, 22:716.
46. Krajewski S., Krajewska M., Turner B.C., Pratt C., Howard B., Zapata J.M., Frenkel V., Robertson S., Ionov Y., Yamamoto H., Perucho M., Takayama S., Reed J.C. Prognostic significance of apoptosis regulators in breast cancer. Endocr. Relat. Cancer 1999, 6:29-40.
47. Lee K.H., Im S.A., Oh D.Y., Lee S.H., Chie E.K., Han W., Kim D.W., Kim T.Y., Park I.A., Noh D.Y., Heo D.S., Ha S.W., Bang Y.J. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. BMC Cancer. 2007, 7:63.
48. Kim K., Chie E.K., Han W., Noh D.Y., Park I.A., Oh D.Y., Im S.A., Kim T.Y., Bang Y.J., Ha S.W. Prognostic value of P53 and bcl-2 expression in patients treated with breast conservative therapy. J. Korean Med. Sci. 2010, 25:235-239.
49. Sastre-Serra J., Valle A., Company M.M., Garau I., Oliver J., Roca P. Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer. Free Radical Biol. Med. 2010, 48:506-512.
50. Derdák Z., Fülöp P., Sabo E., Tavares R., Berthiaume E.P., Resnick M.B., Paragh G., Wands J.R., Baffy G. Enhanced colon tumor induction in uncoupling protein-2 defecient mice is associated with NF-kappa B activation and oxidative stress. Carcinogenesis 2006, 27:956-961.
51. Yonezawa T., Sanosaka M., Haga S., Kobayashi Y., Katoh K., Obara Y. Regulation of uncoupling protein 2 expression by long-chain fatty acids and hormones in bovine mammary epithelial cells. Biochem. Biophys. Res. Commun. 2008, 376:280-285.
52. Master S.R., Hartman J.L., D'Cruz C.M., Moody S.E., Keiper E.A., Ha S.I., Cox J.D., Belka G.K., Chodosh L.A. Functional microarray analysis of mammary organogenesis reveals a developmental role in adaptive thermogenesis. Mol. Endocrinol. 2002, 16:1185-1203.
53. Fleury C., Mignotte B., Vayssiere J.L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002, 84:131-141.